Skip to main content
Erschienen in: European Radiology 6/2006

01.06.2006 | Gastrointestinal

Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging

verfasst von: Arne S. Borthne, Michael Abdelnoor, Trygve Storaas, Claude Pierre-Jerome, Nils-E. Kløw

Erschienen in: European Radiology | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

The aim was to evaluate the importance of the osmolarity of different oral agents for bowel distension and the level of related adverse events. The longitudinal design included the exposition of different oral MR agents on two separate occasions. Four groups of volunteers were randomly given 350 ml gastrografin of three different concentrations and water. On the second occasion they received mannitol, iohexol or iodixanol with equivalent osmolarities, but the control group (water) received mannitol. We recorded the outcomes as the degree of bowel distension determined as the mean bowel section area and the total level of discomfort recorded from a visual analogue scale (VAS). The statistical analysis included scatter plots with the best-fitted line with linear regression to study the association between osmolarity and section area and the association between osmolarity and adverse events. A dose-response association was found between increasing osmolarity levels and bowel area in square centimeters (P=0.00001). A similar dose-response association existed between increasing levels of osmolarity and adverse events (P=0.001). Osmolarity appears to be more important for bowel distension than the physico-chemical characteristics of the nonabsorbable oral agents. The optimum osmolarity level is determined by the patient’s tolerance of the adverse events.
Literatur
1.
Zurück zum Zitat Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin North Am 4:25–35 Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. Magn Reson Imaging Clin North Am 4:25–35
2.
3.
Zurück zum Zitat Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375CrossRefPubMed Giovagnoni A, Fabbri A, Maccioni F (2002) Oral contrast agents in MRI of the gastrointestinal tract. Abdom Imaging 27:367–375CrossRefPubMed
4.
Zurück zum Zitat Schunk K (2002) Small bowel magnetic resonance imaging for imflammatory bowel disease. Top Magn Reson Imaging 13:409–425CrossRefPubMed Schunk K (2002) Small bowel magnetic resonance imaging for imflammatory bowel disease. Top Magn Reson Imaging 13:409–425CrossRefPubMed
5.
Zurück zum Zitat Schwartz D (1981) Méthodes statistiques a l´usage des médecins et des biologistes. Troisieme édition. Flammarion médecine-sciences, Paris ISBN 2-257-10326-2 Schwartz D (1981) Méthodes statistiques a l´usage des médecins et des biologistes. Troisieme édition. Flammarion médecine-sciences, Paris ISBN 2-257-10326-2
6.
Zurück zum Zitat Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717–725PubMed Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H (2000) Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 215:717–725PubMed
7.
Zurück zum Zitat Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P (2000) MR imaging of the small bowel with a true FISP sequence after enteroclysis with water solution. Invest Radiol 35:707–711CrossRefPubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Maris T, Prassopoulos P (2000) MR imaging of the small bowel with a true FISP sequence after enteroclysis with water solution. Invest Radiol 35:707–711CrossRefPubMed
8.
Zurück zum Zitat Schreyer AG, Seitz J, Feuerbach S, Rogler G, Herfarth H (2004) Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis 10:45–54CrossRefPubMed Schreyer AG, Seitz J, Feuerbach S, Rogler G, Herfarth H (2004) Modern imaging using computer tomography and magnetic resonance imaging for inflammatory bowel disease (IBD) AU1. Inflamm Bowel Dis 10:45–54CrossRefPubMed
9.
Zurück zum Zitat Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Rühm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279–283PubMedCrossRef Lauenstein TC, Schneemann H, Vogt FM, Herborn CU, Rühm SG, Debatin JF (2003) Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 228:279–283PubMedCrossRef
10.
Zurück zum Zitat Lomas DJ, Graves MJ (1999) Small bowel MRI using water as a contrast medium. Br J Radiol 72:994–997PubMed Lomas DJ, Graves MJ (1999) Small bowel MRI using water as a contrast medium. Br J Radiol 72:994–997PubMed
11.
Zurück zum Zitat Laghi A, Carbone I, Catalano C, Iannaccone R, Paolantonio P, Baeli I, Trenna S, Passariello R (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR 177:1333–1334PubMed Laghi A, Carbone I, Catalano C, Iannaccone R, Paolantonio P, Baeli I, Trenna S, Passariello R (2001) Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR 177:1333–1334PubMed
12.
Zurück zum Zitat Patak MA, Froehlich JM, von Weymarn C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358:987–988CrossRefPubMed Patak MA, Froehlich JM, von Weymarn C, Ritz MA, Zollikofer CL, Wentz KU (2001) Non-invasive distension of the small bowel for magnetic-resonance imaging. Lancet 358:987–988CrossRefPubMed
13.
Zurück zum Zitat Born C, Nagel B, Leinsinger G, Reiser M (2003) MRI with oral filling in patients with chronic inflammatory bowel diseases. Radiologe 42:34–42CrossRef Born C, Nagel B, Leinsinger G, Reiser M (2003) MRI with oral filling in patients with chronic inflammatory bowel diseases. Radiologe 42:34–42CrossRef
14.
Zurück zum Zitat Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Dose optimization of mannitol solution for small bowel distension in MRI. J Magn Reson Imaging 20:648–653CrossRefPubMed Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Dose optimization of mannitol solution for small bowel distension in MRI. J Magn Reson Imaging 20:648–653CrossRefPubMed
15.
Zurück zum Zitat Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 14:458–464PubMedCrossRef Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC (2004) Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 14:458–464PubMedCrossRef
16.
Zurück zum Zitat Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, Kløw NE (2005) MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol 15:666–671PubMedCrossRef Borthne AS, Abdelnoor M, Hellund JC, Geitung JT, Storaas T, Gjesdal KI, Kløw NE (2005) MR imaging of the small bowel with increasing concentrations of an oral osmotic agent. Eur Radiol 15:666–671PubMedCrossRef
17.
Zurück zum Zitat Ajaj W, Goyen M, Schneemann H, Kuehle C, Nuefer M, Ruehm S, Goehde S, Lauenstein T (2005) Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distension. Eur Radiol 15:1400–1406PubMedCrossRef Ajaj W, Goyen M, Schneemann H, Kuehle C, Nuefer M, Ruehm S, Goehde S, Lauenstein T (2005) Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distension. Eur Radiol 15:1400–1406PubMedCrossRef
18.
Zurück zum Zitat Laerum F, Stordahl A, Solheim KE, Haugstvedt JR, Roald HE, Skinningsrud K (1991) Iodinated contrast agents and the gastrointestinal tract. Intestinal follow-through with iohexol and iopentol. Invest Radiol 26:177–181 Laerum F, Stordahl A, Solheim KE, Haugstvedt JR, Roald HE, Skinningsrud K (1991) Iodinated contrast agents and the gastrointestinal tract. Intestinal follow-through with iohexol and iopentol. Invest Radiol 26:177–181
19.
Zurück zum Zitat Loennemark M, Magnusson A (1995) Oral contrast media in CT of the abdomen. Iohexol of different concentrations as a gastrointestinal contrast medium. Acta Radiol 36:396–398PubMedCrossRef Loennemark M, Magnusson A (1995) Oral contrast media in CT of the abdomen. Iohexol of different concentrations as a gastrointestinal contrast medium. Acta Radiol 36:396–398PubMedCrossRef
20.
Zurück zum Zitat Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Kløw NE (2005) Bowel magnetic resonance imaging of pediatric patients with oral mannitol. MRI compared to endoscopy and intestinal ultrasound. Eur Radiol DOI: 10.1007/s00330-005-2793-y Borthne AS, Abdelnoor M, Rugtveit J, Perminow G, Reiseter T, Kløw NE (2005) Bowel magnetic resonance imaging of pediatric patients with oral mannitol. MRI compared to endoscopy and intestinal ultrasound. Eur Radiol DOI: 10.1007/s00330-005-2793-y
21.
Zurück zum Zitat Bigard M, Gaucher P, Lasalle C (1979) Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 77:1307–1310PubMed Bigard M, Gaucher P, Lasalle C (1979) Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology 77:1307–1310PubMed
Metadaten
Titel
Osmolarity: a decisive parameter of bowel agents in intestinal magnetic resonance imaging
verfasst von
Arne S. Borthne
Michael Abdelnoor
Trygve Storaas
Claude Pierre-Jerome
Nils-E. Kløw
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 6/2006
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-005-0063-7

Weitere Artikel der Ausgabe 6/2006

European Radiology 6/2006 Zur Ausgabe

Letter to the Editor

Reply of Editor-in-Chief

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.